| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
1986-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fddb6e08738475d776814e8afb315802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6a6c2d888d7f65ead9e54ed6b59a2c |
| publicationDate |
1988-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-S63157995-A |
| titleOfInvention |
Anti-human colon carcinoma monoclonal antibody acc-574 |
| abstract |
NEW MATERIAL:Anti-human colon carcinoma monoclonal antibody ACC-574 belonging to IgG1 class and reactive with colon carcinoma. USE:Reagent for pathologic diagnosis of colon carcinoma and a remedy for colon carcinoma. PREPARATION:For example, a fragment of human colon carcinoma membrane is mixed with a aluminum hydroxide, etc., and the mixture is administered to a BALB/c mouse. Spleen cell is collected from the immunized mouse, subjected to cell fusion with a mouse myeloma cell and cultured in HAT medium to obtain a hybridoma. The hybridoma is cloned e.g. by limited dilution analysis to obtain a hybridoma strain capable of producing anti-human colon carcinoma monoclonal antibody. The hybridoma is cultured in a medium or administered to a mouse to obtain ascites and the objective monoclonal antibody ACC-574 is separated from the cultured product or ascites. |
| priorityDate |
1986-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |